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Abstract: Independent component analysis (ICA) is a matrix factorization approach where the signals
captured by each individual matrix factors are optimized to become as mutually independent as
possible. Initially suggested for solving source blind separation problems in various fields, ICA was
shown to be successful in analyzing functional magnetic resonance imaging (fMRI) and other types
of biomedical data. In the last twenty years, ICA became a part of the standard machine learning
toolbox, together with other matrix factorization methods such as principal component analysis (PCA)
and non-negative matrix factorization (NMF). Here, we review a number of recent works where ICA
was shown to be a useful tool for unraveling the complexity of cancer biology from the analysis of
different types of omics data, mainly collected for tumoral samples. Such works highlight the use
of ICA in dimensionality reduction, deconvolution, data pre-processing, meta-analysis, and others
applied to different data types (transcriptome, methylome, proteome, single-cell data). We particularly
focus on the technical aspects of ICA application in omics studies such as using different protocols,
determining the optimal number of components, assessing and improving reproducibility of the ICA
results, and comparison with other popular matrix factorization techniques. We discuss the emerging
ICA applications to the integrative analysis of multi-level omics datasets and introduce a conceptual
view on ICA as a tool for defining functional subsystems of a complex biological system and their
interactions under various conditions. Our review is accompanied by a Jupyter notebook which
illustrates the discussed concepts and provides a practical tool for applying ICA to the analysis of
cancer omics datasets.
Keywords: independent component analysis; cancer; omics data; dimension reduction; data analysis;
data integration
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1. Introduction
Cancer research is one of the most important providers of large-scale molecular profiling data,
which help in understanding not only the state of human cells in disease but also shed light on
the normal physiological processes measurable and detectable in various kinds of omics datasets.
Determining robust and biologically meaningful ways of quantifying cellular and organismal and
normal and pathological physiology using high-throughput molecular data remains a major challenge
(making biology a quantitative science). Different kinds of biological processes leave characteristic
traces at different levels of genome-wide measurements depending on their nature and timescales:
some significantly affect transcriptomes, some rather modify DNA methylation programs or mutational
spectrum, others are measurable only at the level of proteome and phosphoproteome. In order to
reliably quantify some of these biological mechanisms, one will need to design multi-omics signatures
spanning several levels of molecular data descriptions. On top of this, various technical factors
interplay with biological ones, frequently in a way which makes it difficult to clearly distinguish both.
Rarely does molecular data “speak for themselves”: they need to be properly pre-processed,
analyzed in the light of mathematical modeling, statistical assumptions, and prior biological knowledge
and, finally, should be represented at some pre-defined level of abstraction. In this sense, one of
the simplest paradigms of linear mixture of signals plays a pivotal role in the modern molecular data
analysis. In this framework, one assumes that a measurable elementary quantity such as expression of
a single gene is a result of weighted summation of some latent, and not always directly observable,
factor activities which should have associated numerical values. The nature, the number of factors
and the way they are represented numerically can be known or unknown in advance. A toolbox of
existing mathematical approaches provides concrete scenarios in which the additive factors can be
determined and quantified, under acceptance of certain assumptions about the statistical properties of
their numerical values or the weights connecting them to the measurements.
One of the standard methods in such a toolbox is independent component analysis (ICA) having
a long standing history of application to biological data, including the analysis of molecular profiles
(mainly, transcriptomic). Formally, ICA belongs to a family of methods called matrix factorizations
(Figure 1), the most popular other representatives of which are principal component analysis (PCA) or
the very similar singular value decomposition (SVD), and non-negative matrix factorization (NMF).
The first applications of ICA in biology contrasted it to PCA and standard clustering methods and
found that the factors determined through ICA are easier to interpret biologically [1,2]. This raised
an increase in interest of ICA and its applications in various contexts, and, in particular, in cancer
biology [3,4]. The success of ICA can be connected to the nature of the statistical assumptions which
are used to define the method, that match well the underlying high-dimensional distributions of omics
datasets. The principles of ICA are briefly introduced in Section 2.1.
Independent component analysis and matrix factorization approaches are standard methods
in the rapidly growing arsenal of machine learning methods applied to the molecular biology and
medical data. At the same time, remarkable success has recently been achieved in applying deep
learning techniques in certain fields of cancer biology such as clinical imaging of various kinds [5–9].
Deep learning has been successfully used in automating the diagnosis and prognosis of several
cancer types, claiming to be competitive with human pathologists [10,11]. Successful applications of
deep learning methods to multi-omics data have been recently reported, such as in Reference [12].
One should also notice that there exists a certain level of controversy in assessing the actual success
of this rapidly growing area [13] and an important methodological discussion on the “deep” versus
“shallow” methods in real applications [14]. Reviewing any statistical method today should necessarily
take into account the existing intrinsic competition between this relatively recent trend and more
“classical” areas of machine learning, even though many of them, including ICA, are rooted in the
artificial neural network theory [15].
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Over the last decade, significant experience in applying ICA to different kinds of omics data
for addressing various problems has been obtained, including data pre-processing, task of cell type
deconvolution, and meta-analysis of multiple omics datasets (Figure 1c). In this paper, we reviewed
most of the recent achievem ts i computational c ncer biology resear h where ICA was used as the
main data analysis tool. We also discussed the practices of ICA applications which appeared t be
succe sful in various contexts.
This review is accompanied by interactive Jupyter notebook located at https://github.com/sysbio-
curie/ICA-in-Cancer-research-review-materials.
2. Methodology of ICA Application to Cancer Omics Data
2.1. Brief Int duction into Matrix Factorization Applied to Omics Data
Independent component analysis belongs to a family of matrix factorization methods. Each of
these methods takes a rectangular matrix X ∈ RNm of measurements (in sufficiently a large number
of observed samples, N, and with number of observed features, m) as an input and approximates it
as a sum of products of p pairs of vectors of size N and m. The fundamental equation for all matrix
factorization methods states (note that the product of ak and sk vectors gives a one-rank matrix of the
same dimension as X):
X ≈
∑p
k=1
ak × sk (∗) (1)
and the problem of matrix factorization is to find a set of ak and sk such that:
‖X−
∑p
k=1
ak × sk‖2 → min (∗∗) (2)
where ‖..‖ is a suitable matrix norm which is most frequently the sum of the Euclidean norms of the
columns of the matrix.
Int. J. Mol. Sci. 2019, 20, 4414 4 of 27
Each vector pair ak and sk will be called a component throughout this review. Therefore, a
component is represented by a vector sk of size m containing weights of omics variables (genes, proteins,
CpG sites, etc.). At the same time a component is associated to a vector ak of size N, containing
contributions of the component to measured samples. We will use these notations and meaning of ak
and sk vectors throughout the whole review.
In the matrix factorization literature, various terms are used to denote the elements of the vectors
ak and sk. For example, the terms “loadings”, “activations”, “factor strength” or “sample-associated
weights” have been used to denote the elements of ak vectors. The matrix composed from the ak
vectors is sometimes called the “mixing matrix” and denoted as A. The elements of sk vectors have
been called “weights of the component” or “signals” and the matrix composed of them (denoted as S)
is sometimes called the “signal matrix”. Moreover, sk vectors themselves are frequently referred to as
“components” or “factors”.
In the context of transcriptomic data analysis, the sk vector is frequently named a metagene [16];
in the case of other data types one can use similar naming, e.g., a metaCpG for the analysis of DNA
methylation profiles. Further we will use the term metagene (or metagene weights for the individual
elements) to refer to vector sk even when describing application of ICA to various data types. Similarly,
the ak vectors are sometimes called metasamples, and we will adopt this term in the text (referring to
the individual vector elements as metasample weights), see Figure 1a.
Intuitively, a transcriptome of a biological sample is described as a combined action of p metagenes.
Each metagene abstractly represents a molecular program (called a functional subsystem further in the
text) by assigning a numerical weight to each gene of the organismal genome. The activity of metagenes
in a sample is combined additively, and each metagene acts on a sample with a sample-specific
strength or activity. Activities of the same metagene over all measured samples is called a metasample.
A metasample is the profile of the corresponding metagene activity similarly to a gene expression
profile across samples.
In the equation (*), only the X matrix is known; the ak and sk vectors are unknown. As such, the
problem of matrix factorization (**) is heavily underdetermined, and additional constraints need to be
introduced on ak and sk vectors in order to find its solution. First of all, it can be required that the all
ak vectors would have length one.
Furthermore, one can require orthogonality of the ak vectors: (ai,aj) = 0, for i , j and that the
solution of (**) should give the same result for different orders of matrix decomposition p, i.e., ak
and sk vectors computed for the order p = p’ would be the same as for the decomposition of order
p” > p’. In this case, solving (**) is equivalent to computing the singular value decomposition (SVD) of
X and gives a set of principal components. There exist several ways to introduce PCA, as reviewed in
Reference [17].
Alternatively, one can require that all elements of ak and sk vectors would be non-negative.
This constrains the problem (**) and leads to NMF. The simplest approach to solve (**) with these
constraints is to repetitively apply the non-negative least squares regression method, considering
ak as unknown at one iteration and sk as unknown at the next iteration, until convergence to a
local minimum.
When computing ICA, the resulting components are required to be as mutually independent as possible.
More precisely, the elements of vectors sk (or sometimes, vectors ak) have to represent maximally
mutually independent distributions, for different k. The perfect independence would mean that the joint
probability distribution P(s1, . . . ,sp) can be factorized as P(s1, . . . , sp) = P1(s1) × P2(s2) . . .× Pp(sp).
Here, one assumes that the elements of vectors sk are i.i.d. samples of the underlying probability
distributions Pk(sk).
From the different nature of the constraints follow different properties of matrix factorization
algorithms (see Reference [18] and Figure 2a). The PCA solves a convex quadratic optimization
problem, which has a unique global minimum. The principal components are orthogonal and can be
naturally ranked by the amount of explained variance. The NMF and ICA problems are not convex;
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therefore, the algorithms used to solve the optimization problem provide solutions depending on the
component initialization. By construction, NMF and ICA do not lead to an orthogonal set of ak vectors
and the components cannot be naturally ranked. The NMF components contain only non-negative
elements, which makes the intuitive picture of the additive action of metagenes simpler to interpret,
while in PCA and ICA some metagenes can cancel the action of other metagenes if they are summed
up with different signs.
2.2. ICA Algorithms
One of the historically first and still popular practical algorithms for solving ICA problem is based
on the general Infomax (or maximum entropy) principle [19]. Indeed, the problem of ICA consists in
minimizing the mutual information among individual components (represented by finite sk vectors).
It can be shown that maximizing entropy of joint distributions of pairs of sk leads to minimizing their
mutual information.
It appeared also that under some assumptions, minimizing the mutual information is equivalent
to maximizing the non-Gaussianity of the individual sk distributions [20]. Quantification of
non-Gaussianity for continuous distributions involves negentropy (or Gibbs free energy, in physics).
Negentropy measures the departure from Gaussianity of a random vector of density P(u) by comparing
its entropy to the entropy of a normal distribution with same mean and variance. The entropy is
defined with a negative sign (S = − ∫ P(u)logP(u)du) and the negentropy is, therefore, a non-negative
function reaching zero only for the standardized normal distribution. For the mathematical details,
we refer the reader to the classical works [19,20].
Since the length of the sk or ak vectors is always finite in real-life applications, one needs to
introduce the way to effectively approximate it from the finite samples. For this purpose, various
surrogate functions (called non-linearity functions) have been proposed, one the most popular
of which involving the kurtosis. Empirically, kurtosis was found to be an appropriate choice of
non-linearity in the analysis of transcriptomic data. Other types of non-linearity functions have
been suggested; however, the appropriate choice of non-linearity for applying ICA to different
kinds of omics measurements remains an open question. The two most popular ICA algorithms
based on non-Gaussianity maximization are fastICA [20] and joint approximation diagonalization
of Eigen-matrices (JADE) [21]. Most of the recent applications of ICA to omics data were based on
fastICA, utilizing approximate Newton iterations to optimize a non-Gaussianity measure. However,
other approaches to computing independent components have been used such as the product density
estimation-based method (ProDenICA), claimed to have higher sensitivity to a wider range of source
distributions than fastICA [22,23].
A typical preprocessing step used before application of ICA algorithms is the so-called data
whitening or sphering (see Figure 1b). Whitening imposes unit variance along each axis. It consists
of choosing a number of significant principal components, thus defining the resulting number of
factors and then rotating the data to the basis of principal Gaussian ellipsoid axes and scaling along the
principal axes to the unit variance. In the geometrical language, the Mahalanobis metrics are introduced
into the data space instead of the usual Euclidean. Therefore, after whitening, the covariance matrix of
the reduced dataset becomes the identity matrix and PCA becomes inapplicable, since all Gaussian
signals have been erased from the data. This makes the use of higher-order moments for finding a
rotation of the orthonormal coordinate basis easier, which would maximize the non-Gaussianity of the
data point projection distributions along each axis. After such a rotation, in the whitened space, the
vectors corresponding to the new axes remain orthogonal while in the original data space they can
be strongly correlated (see Figure 2a). Because of the use of whitening as a preprocessing procedure,
ICA is frequently considered as a step on top of PCA, consisting in rotating the coordinate system,
by exploiting the information contained in higher than second moments of the multivariate data
distribution (Figure 1c).
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Various flavors of ICA have been suggested and some of them were tried on omics data. Bayesian
ICA with prior constraints have been suggested and tried on the metabolomics data [24]. The prior
constraints can be non-negativity of the ak and sk vector elements. This allows combining the nice
properties of non-negative mixture problem and the requirement for mutual independence of the
components. A kernel version of ICA have been developed [25] and sparse ICA was proposed in
Reference [26], but both have not yet found wide applications in omics data analysis (though kernel ICA
was exploited in Reference [27]). Finally, tensorial ICA was recently developed in References [28,29] and
recently applied to the joint analysis of gene expression, copy number changes, and DNA methylation
data from colon cancer with some promising results (see more in Section 3.5).
Some flavors of ICA seems interesting to explore more in biological applications, in the view
of the concept of the integration of functional subsystems (see Section 3.6), such as tree-dependent
component analysis (TCA) [30]. This variant of ICA allows clustering of the components such that
they remain independent between the clusters and dependent within them. It was tested on fMRI
data [31], but not yet on large-scale omics datasets.
2.3. Various Ways to Apply ICA to Omics Data
Besides the choice of ICA algorithm (which is frequently fastICA), there are several choices to be
made when ICA is applied to omics datasets.
The first evident but non-trivial choice concerns a necessity for data log-transformation, which
is especially important in the case of gene expression and protein expression data. On one hand,
it is strongly desirable in the case of, for example, RNA-Seq data, since empirically they are found
to be characterized by log-normal distribution. When ICA is applied to non-transformed data, the
resulting components are frequently dominated by single genes or single samples (e.g., each sample
acts as an independent component), which contradicts the initial concept of linear mixture (nothing or
almost nothing is mixed in this case). Simple log-transformation usually fixes this issue. However,
log-transformation makes the direct interpretation of the ICA model difficult, since, formally speaking,
one deals with a multiplicative rather than an additive model of signal mixture. This is particularly
important for the applications of ICA in the field of cell type deconvolution where the linearity
assumption is explicitly made for mixing transcriptomes of different cell types (see Reference [32]
which cites a number of references studying the issue of data log transformation). Another aspect
is that log-transformation can amplify small values, sometimes creating a heavy tail of negative
values, characterized by strong non-Gaussianity and affecting the ICA determination. In practice,
log-transformation can be recommended after adding a small value (e.g., 1 sequence count) to all data
matrix entries, before taking the log. This is especially true in the case of sparse single cell RNA-Seq
data, where the majority of matrix entries can equal to zero. On the other hand, choosing a threshold
for small expression values looks like an arbitrary choice, especially if the RNA-Seq data have been
normalized beforehand. Despite these difficulties, in most of the applications of ICA to RNA-Seq data
analysis, the so called “log(x+1)” transformation can be advised: empirically, it is found to lead to
more stable and biologically interpretable components. The problem of log transformation became
more relevant after introducing sequencing technologies such as RNA-Seq; for microarray-based
methods, the gene expression measurements were frequently provided in log scale, after some standard
normalizations such as robust multichip average.
Another choice in applying ICA to a matrix of omics measurements is the choice between
what distribution independence (or non-Gaussianity) is maximized [18]. One can maximize the
independence of metagenes (vectors sk) or metasamples (vectors ak). Technically, the first case
corresponds to the application of ICA algorithm to the initial matrix X containing samples as rows
and omics variables as columns, and the second case corresponds to the application of ICA to
the transposed matrix X. Surprisingly, both ways of applying ICA to omics data are wide-spread,
and sometimes it makes an effort to figure out in which way ICA was applied. Some studies aim at
maximizing the non-Gaussianity of metagenes [2,33–35], while others maximize non-Gaussianity of
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metasamples [36,37]. Empirically it was shown that maximizing the non-Gaussianity of metagenes is
clearly preferable in gene expression analyses to maximizing the non-Gaussianity of metasamples [38].
This choice leads to much better reproducibility of metagenes in independent datasets as well as to
better interpretability of the components computed within the same dataset.
Furthermore, in several studies it was found that stabilized or consensus independent components
have better characteristics in terms of generalization and interpretation [34,38–41]. By stabilization one
usually means re-computing ICA using multiple random initialization with subsequent clustering of
the resulting components [40,41]. Alternatively, stabilization can be performed through sub-sampling,
i.e., computing ICA multiple times after removing a certain percentage of samples. Applying
stabilization can characterize computed independent components in terms of their stability that can
be further used for ranking them. For example, it was demonstrated that such ranking is usually
more meaningful in the case of transcriptomic data analysis compared to other methods of component
ranking (e.g., by the measure of non-Gaussianity or by the explained variance) [34]. One of the first
and most popular approaches to ICA stabilization is the icasso method, introduced by the creators of
fastICA [41]. Interestingly, in the case of transcriptomics data, the most stable independent component
frequently strongly correlates with the first principal component.
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(or deconvolute) two intersecting Gaussian distributions with coinciding means and whose principal
axes form a sharp angle; (b) 100 order ICA decomposition of the TCGA and METABRIC datasets.
Each component represented as a metagene was correlated to either immune infiltration-related or
proliferation-related meta-metagenes derived from Reference [33]. This analysis shows that only one
of the components was strongly correlated to the cell-cycle, while several can be associated with
the presence of an immune-infiltrated ICA-derived signature (this, probably, signifies the ability of
ICA to deconvolute the major immune cell types in an unsupervised manner (see, Reference [42]);
(c) correlations matrix between the metagenes of independent components extracted from the TCGA
and METABRIC separately. It shows that, for some components computed for different datasets, there
exists a strong and unique association between them, indicating the high reproducibility of the ICA
results (e.g., see Reference [38]).
Lastly, in some applications of ICA (e.g., cell-type deconvolution), it is desirable to fix the
orientation of the independent components. We remind that in PCA and ICA, the signs of the
elements in the vectors ak and sk can be inverted simultaneously without changing the definition of the
component. Some methods (such as BIODICA or DeconICA) avoid this ambiguity by assuming that the
heaviest tail of the sk distribution should correspond to positive values, which usually gives satisfactory
results. In Reference [43], each ICA component was characterized by two sets of top contributing
genes, from the negative and the positive side of the metagene weight distribution. The largest such
set was called a dominating module and the final orientation of the component was chosen to make the
weights of the dominating module positive. In other cases, labeling of samples can be used in order to
select one of the two possible signs of ak and sk. In this case, the orientation was chosen based on the
values of ak vectors. For example, in a disease study, one can require that any component would be
oriented towards aggravation of the disease condition (e.g., from normal samples to more aggressive
cancer stages). This approach was recently used for quantifying disease comorbidity using ICA [44].
2.4. Assessment and Comparison with Other Matrix Factorization Methods
In several recent studies, ICA was systematically compared with the other most used matrix
factorization methods such as PCA and NMF, using large collections of cancer omics measurements.
In Reference [38], it was tested which matrix factorization method could produce the most
reproducible (i.e., generalizable) definitions of metagenes. In order to achieve this, a notion of a
reciprocal best hit (RBH) graph was borrowed from evolutionary bioinformatics. Reciprocal best
hit between two metagenes in two ICA decompositions of different datasets defined “orthologous”
metagenes. Several criteria have been used in order to evaluate the modular structure of the RBH graphs
resulting from application of various ways of applying ICA, PCA, and NMF to the transcriptomic
data. In particular, the total number of RBH relations among the components, average clustering
coefficient and modularity of the RBH graph, and the number and typical sizes of the identified graph
communities have been assessed. The conclusion was that the stabilized version of ICA, where the
non-Gaussianity of metagenes (and not metasamples) was maximized, is superior to other matrix
factorization methods with respect to these measurements.
Three major matrix factorization approaches were systematically discussed in a recent review for
their ability to discover functional subsystems or tissue-type specific signals [45]. The main conclusion
was that it might be advantageous to use several matrix factorizations simultaneously. The same
authors further suggested using the BioBombe approach [46], where three matrix factorization methods
(PCA, ICA, and NMF) and two autoencoder-based dimension reduction techniques were systematically
compared based on the pancancer TCGA datasets comprising 11,069 tumoral samples. Indeed, each
data decomposition method showed its own advantages with respect to different tests and tasks.
For example, the ICA method outperformed other approaches when the extracted metagenes were
tested for gene set coverage of specific gene set collections representing transcription factor targets,
Reactome pathways, and cancer modules. Higher gene set coverage in this study meant the proportion
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of gene sets in a reference collection, which could be significantly associated with one of the metagenes
in the decomposition.
2.5. Estimating the Number of Independent Components
The most important parameter in the application of any matrix factorization method is the number
of components to determine. This question is less crucial in the case of PCA due to the orthogonality
constraint and that computing higher-order components does not affect the definition of the lower-order
ones. However, this is not the case with ICA and NMF: choosing the order of decomposition affects
the definition of all computed components. In the case of ICA, which geometrically only rotates
the PCA axes, choosing the number of independent components can rely either on the methods
for determining the number of relevant principal components or it can use some features of the
independent components themselves in order to determine the optimal decomposition order.
In the first case, the effective global dimensionality of the data can be determined through
the standard Kaiser rule, use of broken stick distribution, Horn’s parallel analysis or estimating
the conditional number of the covariance matrix [47]. One can also use more advanced methods
for determining the effective data dimensionality such as the ones using concentration of measure
phenomena [48] or data point cloud linear separability statistics [49].
However, the second case appears to be more consistent in applications, even being computationally
more challenging. Thus, in Reference [24], Bayesian information criterion (BIC) was exploited to
determine the optimal number of independent components in the analysis of a metabolome dataset
comprising 1764 samples and 218 measured metabolites. The optimal number of components according
to this estimate appeared to be quite small (eight).
In Reference [34] stability indices of independent components were used in order to define
so-called maximally stable transcriptomic dimensionality (MSTD) measure, in case of transcriptomic
data. The MSTD defines an order of transcriptomic matrix decomposition such that the distribution of
stability indices for independent components is not yet dominated by highly unstable ones. It was
demonstrated that the independent components within the MSTD range are characterized by better
reproducibility and interpretability. Based on the analysis of a large volume of cancer transcriptomic
data, several observations were made. Firstly, unstable higher order components are frequently driven
by very few (frequently, only one) genes. In other words, their sk distributions are characterized by the
presence of one or few weights with exceptionally large values, separated by a significant gap from the
other values. Secondly, it was shown that a certain level of over-decomposition of transcriptomic datasets,
i.e., choosing the number of independent components several times larger than MSTD, does not
drastically change the definition of most of the components within the MSTD range. At the same
time, it was observed that increasing the number of independent components over the MSTD value
sometimes leads to biologically meaningful splitting of the components. For example, a component
within the MSTD range which was associated with the total level of immune infiltrate in tumoral
microenvironment splits into three components in higher-order decompositions which can be associated
with the presence of T-cells, B-cells, and macrophages [34,42].
In Reference [46], a range of decomposition orders have been tested using various criteria for
several matrix factorization methods. The general conclusion was that it can be advantageous to
use multiple-order decompositions if the aim is signature discovery. Just as in Reference [34], it was
shown that higher-order matrix factorizations with at least 40–50 components provide more precise
interpretation with respect to associating the components to the clinical information such as patient
gender or to the mutation status of cancer driver genes.
2.6. Methods for Interpretation of Independent Components
Assigning a meaning to the extracted independent factors remains a major problem in exploiting
ICA in biological research. Standard practice consists of applying various kinds of functional enrichment
analyses to sk vectors (e.g., applying hypergeometric test or overrepresentation analysis (Webgestalt
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2017) to the set of most contributing genes, or Gene Set Enrichment Analysis to the whole ranking
defined by sk), using large-scale collections of reference gene sets. The distribution of gene weights
from sk vectors can be projected on top of genome-wide biological network reconstructions where
the network edges represent different types of interactions or regulations between genes and/or
proteins. This can be further used for various types of network-based analyses, leading to the
determination of biological network “hotspot” areas and eliminating the need of having a reference
gene set collection [50]. The sk vectors (resulting from the analysis of transcriptomic or methylome
data) can be projected onto genome and be a subject of peak-calling analysis, which can sometimes
lead to associating a component to genomic alterations [33].
Metasample weights ak are used to associate components to sample annotations such as clinical
data (tumor stage, molecular classification, time label, sample processing data, etc.). Metasamples
can be also associated with some clinically relevant molecular data, such as mutations in known
cancer drivers for a particular cancer type. Metasamples can be also associated with known labels for
molecular tumor subtype.
In parallel to rigorous statistical testing, insightful visualizations of the results of ICA application
can be of great help. For example, gene weights from sk vector can be projected on cancer-specific
biological network maps such as the Atlas of Cancer Signaling Network (ACSN) using user-friendly
Google Maps-based online platforms such as NaviCell and MINERVA [51,52]. Functional enrichment
analysis results of ICA metagenes can be visualized using maps representing functional redundancy
between reference gene sets, such as InfoSigMap or enrichment maps [53].
There exist integrated solutions allowing the computation of ICA components for omics datasets
and containing a built-in set of tools for their interpretation. For example, in the BIODICA package
(Available online: https://github.com/LabBandSB/BIODICA), a set of tools is provided for performing
hypergeometric tests of the metagenes, automated feeding of Gene Set Enrichment Analysis with ICA
metagenes, projecting metagenes onto biological network maps, correlating computed metagenes with
a reference database of previously annotated metagenes, associating components with categorical and
numerical sample annotations, and tools for meta-analysis of ICA decompositions.
A particular interest represents joint analysis of omics profiles together with histopathological
imaging data. A simple analysis was made in Reference [33], where the independent components
computed from the transcriptomic data were used to rank the matched histopathological images
according to the contribution of the corresponding tumor sample to the component. This simple
approach was used in order to confirm the biological meaning of some of the components (see Figure 3).
Today this approach can be further elaborated and automated by applying machine learning-based
methods for extracting features from medical images and correlating them to the patterns identified
from the omics data (such as ICA metagenes), which can lead to getting new insights into cancer
biology [54].
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3. Applications of ICA in Cancer Research
3.1. Applications to Data Preprocessing, Classification, Dimensionality Reduction, and Clustering
In multiple studies, ICA was shown to be efficient in disentangling biological and technical factors
affecting molecular profiles. This supports the idea to use ICA as a powerful data preprocessing and/or
feature engineering method for further application of machine learning methods. The general approach
is to apply ICA as an unsupervised machine learning method, to decide on the biological meaning
or the technical origin of individual components and then focus on a subset of them containing the
relevant signal. This can be achieved either by directly using the relevant subset of components as
features or by constructing a modified matrix of molecular measurements which would be free of the
influence of those components which are identified as non-relevant or of technical origin.
Frequently, each one-dimensional sk distribution is analyzed for determining a set of the most
contributing genes (e.g., characterized by the most extreme absolute values in sk). The simplest idea is
to select the variables (e.g., genes) bypassing the threshold in p standard deviations, with some choice
for p (typically, p ≥ 3). A combined set of the most contributing to different ICs genes can be used to
define a subset of data for further analysis.
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Interestingly, ICA decomposition can be used to identify and disregard technical biases among
omics datasets produced by different platforms. For example, in the study of 198 bladder cancers
in Reference [33], one of the most stable components was found to be associated with a complex
time-dependent batch effect. The nature of this batch was not known in advance and was only
discovered by correlating the corresponding ak vector to the dates of sample preparation. Another
component frequently identified in the analysis of transcriptomic data is related to GC-content,
which might reflect the influence of GC-content on the RNA amplification step common for both
microarray-based and sequencing-based methodologies. In Reference [39], a small dataset of three
primary melanoma tumors and two matched controls, characterized at the level of transcriptome and
miRNA, were merged together with a large reference melanoma dataset from the Cancer Genome Atlas.
The ICA decomposition was performed for the merged transcriptomic and miRNA data separately.
For both molecular data types, it was possible to identify those independent components capturing
technical differences among platforms while focusing the analysis on biologically meaningful factors
whose quantification was comparable among platforms.
Interestingly, ICA-based analysis sometimes can lead to identification of the factors whose
origin is intermediate between technical and biological. For example, in Reference [33] one of the
factors reproducible in several bladder cancer datasets was strongly associated with the surgery
type (transurethral resection of the bladder tumor versus cystectomy) and at the same time was
enriched with early response genes. This suggests that different ways of tissue processing might leave
characteristic patterns in the transcriptome which can be discovered using ICA.
Some components identified through ICA could describe various cell populations present in the
sample in addition to cells of direct interest. Typically, this was the case for the stroma-related signals
in the ICA-based analysis of tumor bulk samples (see Figure 2). ICA can efficiently deconvolute the
contribution from the cells of different types to the bulk transcriptome, which allows studying the
properties of tumor cells more directly. In the aforementioned study of bladder cancer, decomposition
of bulk tumors into 20 components allowed for the clear distinction of the signals reflecting the presence
of immune cells (with the main signal coming from the multiple types of lymphocytes, adipocytes,
fibroblasts [33].
Another frequently employed idea is to use the results of ICA decomposition in order to define a
set of variables for further application of various machine learning methods. Zhang et al. [55] were
among the first who applied ICA as a data-preprocessing step for classification of cancer patients.
They used ICA independently on normal and cancer datasets and identified top gene markers able to
discriminate between these conditions. Their approach was quite indirect but showed the ability of
ICA to prioritize genes. In a study by Huang et al. [56], ICA was followed by a penalized discriminant
method, and the authors showed high accuracy of ICA-based approach on several datasets. In both
mentioned papers, the authors segregated cancer and normal tissues, which is now considered a
trivial task, taking into account the large effect of cancer on cell transcriptome. Later, Zheng et al. [57]
proposed a consensus ICA, robust to initial estimations. They showed the applicability of the approach
on three datasets, in two of which they classified subtypes of tumors. Support vector machine (SVM)
was used to predict classes based on the metasamples, and the authors needed to perform preliminary
feature selection to improve their classification accuracy.
Recently ICA was used to engineer features for further use in cancer-related classification
tasks, using naïve Bayes classifier [58]. In Reference [59], ICA was used as a data pre-processing
step in order to improve the clustering of temporal RNA-Seq data. It was suggested to use ICA in
combination with wavelet-based data transformation in order to engineer transcriptomic features at
“multiple resolution” [60] and use them to improve tumor classification and biomarker discovery.
In Reference [22], it was shown that a set of 139 features built by systematically applying ICA to a
large cohort of transcriptomic profiles, can be directly used in machine learning for classification tasks
and have advantageous characteristics in small sample studies, compared to the classical differential
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expression-based feature selection. It was noticed also that using ICA-based features reduced to some
extent the batch effects when clustering the transcriptomic data.
Any matrix factorization method can be used for dimensionality reduction. The specifics of ICA
are in that it is usually performed in an already reduced space and only defines a new coordinate basis
in the principal linear manifold. Therefore, ICA itself does not reduce the data dimension more that it
is done by PCA. Nevertheless, it is a frequent practice to consider the coordinate basis defined by few
independent components as a subspace to further application of various data analyses. For example,
this approach is used for a standard pipeline of single cell RNA-Seq data analysis [61]. Similar notice
can be made with respect to using ICA as a data visualization tool. Selecting a couple of independent
components with clearly identified biological meaning can lead to a biologically meaningful 2D
data display. For example, in Reference [62], visualizing a single cell dataset in the plane of two
independent components associated with proliferative genes clearly revealed the 2D dynamics of
tumor cell progression through the cell cycle. The difference with PCA-based data visualization is that,
in the case of ICA, there exists no principal pair of components (such as PC1 and PC2) which can be
considered as the most representative for visualizing the multi-dimensional distances. This remark
should be taken with care since, frequently, the first PCs are affected by technical artifacts and are to be
neglected in further analysis. In the case of ICA, any pair of ICs in no particular order can be used for
data visualization taking into account their tentative interpretation. Examples of contrasting PCA and
ICA approaches for data visualization can be found in References [37].
3.2. ICA for Unraveling Functional Subsystems of a Living Cell or a Cell Ecosystem
One of the strongest motivations behind applications of ICA to omics data is in that it can help
identifying functional subsystems (or functional modules and complex biological processes) which
are the building blocks determining response to perturbation of a tumoral cell or a whole cellular
ecosystem such as tumor microenvironment (TME) composed of different cell types. The underlying
principle is that genes or proteins do not react to an external stimulus individually but always integrate
into a (sub-)system with more or less defined limits. Importantly, it is biologically feasible to assume
the phenomenon of plurifunctionality, i.e., potential participation of an elementary entity (such as gene
or protein) into several functional subsystems.
The composition of a functional subsystem is defined by a matrix factorization method in the form
of the sk vector (weights associated with the omics variables) or metagene. The level of activation (or
inhibition) of an identified functional subsystem sk can be read in the corresponding metasample vector
ak. The same is relevant for an independent component associated with a technical factor intensity.
If no explicit sparsity constraint is imposed when computing the vectors, then each omics variable
(gene, protein) has a non-zero contribution (estimated by its weight in sk) to the definition of the
subsystem, which can be positive or negative. However, those variables having close to zero weights
can be neglected from the subsystem definition. An important characteristic of a metagene is the
set of the most contributing genes (see discussion in the previous section). The most contributing
genes are useful to characterize the functional subsystem and to identify if this subsystem corresponds
to an existing known one. After determination of the sets of the most contributing genes per each
metagene (functional subsystem), one can check if a gene is associated with the subsystem exclusively
or contributes to several ones. This analysis can be used to identify potential coupling between the
subsystems and their concrete mechanisms (see further discussion). Sometimes it is convenient to
distinguish two gene sets per metagene, having the largest and the smallest set of weights, from the
positive and the negative sides of the sk distribution.
We can distinguish two types of functional subsystem response. One is due to the mechanistic
downstream effect of a stimulus, i.e., through an induction of a transcription factor downstream of a
signaling pathway. Another type is a more systemic one, indirect and related to a longer time scale,
caused by an adaptation of the whole system to the presence of potentially harmful factors (such
as hypoxia or active immune response) [63,64]. If a studied system’s response (e.g., a tumor cell) is
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measured in a sufficiently variable number of conditions or perturbation types, one can hope to identify
the composition of the most relevant/responsive functional subsystems by applying an appropriate
machine learning methodology.
Identification of functional subsystems (modules) from cancer omics data was first historically
approached with hierarchical clustering of genes [65]. Matrix factorization in this sense seems to
be a more suitable mathematical formalism since it naturally allows taking into account the gene
plurifunctionality. This is a simple consequence of a gene that can significantly contribute (i.e., be in
the list of the most contributing genes) to the definition of several functional subsystems. ICA is a
powerful approach here, because the requirement of maximally possible statistical independence seems
to be well suited for the task of subsystem identification. Even if the activity of a pair of functional
subsystems is correlated in the most of observed conditions, ICA can still distinguish them based
on a smaller number of conditions when they de-synchronize (see a discussion of this aspect in the
methodological part of the review). This ability of ICA is also powerful in disentangling the technical
biases from biologically relevant signals (as discussed in Section 3.1), making the identification of the
functional subsystems less prone to technical biases. Last but not least, ICA allows taking into account
the case when the activation of a functional subsystem is connected to inhibition of some of the genes
or proteins. One of the simple examples of such a situation is when a transcription factor has a role of
an activator for some genes and an inhibitor for other genes.
Functional subsystems identified by ICA can reveal an important coupling of several known
biological mechanisms and relate it to the biological phenotype such as cancer patient outcome. In the
case of breast cancer, this phenomenon was described in Reference [27] through so-called ICA-based
association networks.
One important characteristics of the weight distribution composing ak is the unimodal or bi- or
multi-modal character of the distribution. In the case of well-defined bimodality of a metasample, one
can stratify the distribution of samples into two groups, with respect to the nature of the functional
subsystem identified. A typical example of this kind is the identification of the functional subsystem of
proliferation in single-cell RNA-Seq data, where the corresponding metasamples frequently have two
modes, corresponding to proliferative and non-proliferative cell states.
Functional subsystems have been systematically identified using ICA from a large cohort of
transcriptomic profiles in Reference [43], where 298 Gene Expression Omnibus (GEO) datasets profiling
9395 human samples (from various conditions including cancer samples) were used to identify 423
“fundamental components of human biology”. As an example of their use, the authors characterized the
molecular mechanisms of parthenolide anti-cancer drug action. Recently, similar large-scale analysis
has been applied to a larger dataset, containing 2753 datasets and 97,049 samples [22]. Compared to
the earlier study, the authors improved the methodology in order to avoid redundant and correlated
transcriptional component definitions, applying Horn’s parallel analysis in order to select the optimal
number of components and systematically evaluating the components’ reproducibility after resampling.
This analysis resulted in defining 139 reproducible and informative transcriptional modules whose
value for the downstream analysis was explicitly demonstrated.
Identification of the functional subsystems and distinguishing them from potentially technology
driven factors can be strongly improved by the application of ICA analysis to multiple similar datasets
independently (without merging them). In this scenario, the ICA results from several datasets were
compared with each other in terms of the correlation or other suitable similarity measure among
metagenes (Figure 4). In the case of cancer, one of the first applications of this approach was done
in Reference [27] for 800 breast cancer samples from four independently profiled cohorts with a
conclusion that independent components matched well the underlying cancer mechanisms. This type
of meta-analysis was further upscaled in Reference [33], where 22 non-redundant cancer transcriptomic
datasets were analyzed. Some of the datasets were related to the same cancer type, i.e., eight of them
were collecting samples of bladder cancer and six were from breast cancer. Because the datasets used in
this study were produced using different technological platforms, this analysis identified the technical
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biases captured by individual components in specific datasets and not reproduced among others.
It also distinguished cancer type-specific functional subsystems (such as differentiation program of
urothelial tissue) and generic and potential pancancer-wise important functional subsystems (such as
the transcriptional program of proliferation or oxphos). Interestingly, one of the bladder cancer-specific
components associated with differentiation of urothelial tissue was also associated with amplification of
a genomic region, containing a particular transcription factor (PPARG). This led to a conclusion about the
role of PPARG in differentiated bladder tumors which was validated experimentally. In Reference [38],
14 non-redundant colon cancer transcriptomic datasets were analyzed by ICA, and the resulting sk
vectors were matched with each other through correlation in order to reveal the functional modules
implicated in colon cancer tumor cells’ and the variability of tumoral microenvironment.
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of two sets of ICA metagenes led to an asymmetric correlation matrix (same as in Figure 2c) which can
be converted to a graph using some threshold and selecting the maximal correlations. If two components
are maximally correlated with each other, then such a correlation defines reciprocal best hit (RBH).
(b) Graph of maximal correlations (reciprocal and not) exceeding certain threshold among components
computed for 22 cancer transcriptomic dataset. Each node is a component, and an edge denotes a
correlation. Color reflects the cancer type (e.g., red is bladder cancer). Communities in this graph
define highly reproducible cancer type-specific and universal latent factors The figure is reproduced
with permission from Reference [33].
In the case of a very good match between ICA-based metagene definitions from several independent
datasets, one can define a consensus metagene definition from the meta-analysis (a meta-metagene).
An exemplary set of such reference metagenes was built in Reference [33] and used in other studies
to facilitate the interpretation of the ICA results. This set included (a) ICA-derived and universal for
many cancer types of proliferation-, oxphos-, immune infiltration-, interferon signaling-associated
metagenes; (b) consensus metagenes associated with the presence of non-tumor cells of several types
in TME; and (c) bladder cancer-specific transcriptional modules (such as differentiation program
of urothelial tissue). A comprehensive catalogue of ICs identified in the pan-cancer TCGA dataset
containing 32 cancer types was produced in Reference [34]. It appears to be a useful effort to extend the
collection of reference consensus metagenes, since they seem to be highly generalizable (reproducible
in independent datasets) [22,38].
3.3. Applications to Unsupervised Cell Type Deconvolution
In cancer biology, bulk omics data (especially transcriptome and methylome) represent heterogeneous
samples such as peripheral blood mononuclear cell (PBMC) and tumor biopsies, in which the expression
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profiles of distinct cell types are mixed in each sample at a priori unknown proportions. The tumor
microenvironment is composed of many different cells including a plethora of immune cells, stromal
cells, and blood and lymphatic vessels [66]. The quantities and the nature of the TME compartments
change with the cancer type and cancer stage. Recent works showed that immune cells could influence
tumor cells in different ways and that the immune therapies take advantage of the protective function
of the immune system and aim to activate patients’ immune defense.
Therefore, one of the major challenges for computational analysis of bulk samples is evaluating
the proportions and the properties of individual cell types composing the sample, frequently called
deconvolution problem in this context [32]. In general terms, deconvolution stands for unmixing a
mixture, which makes it close to the blind source separation methods, including ICA (Figure 5a).
Deconvolution of cancer bulk transcriptomes gained a lot of popularity in the last several years
due to the abundance of data sources. Several methods were proposed to estimate the abundance
of immune infiltration in cancers at different levels of granularity [67–70] using a pre-defined set of
genes, usually generated from pure blood cell population gene expression data [67,68], from single-cell
RNA-Seq measurements [70] or mixed [69]. They were proven to correctly estimate the cell-type
abundance in silico simulated datasets, in vitro cell mixtures, and blood or PBMC transcriptomes
coupled with fluorescence-activated cell sorting (FACS) estimations. However, it remains unclear how
many cell types or cell states can be quantified from bulk transcriptomes as each tool comes with own
definition of cell-types (e.g., T-cell) and subtypes (e.g., CD4-activated T-cell) or cell states (e.g., cytotoxic
T-cell).
In response to this problem, reference-free (also called unsupervised) approaches propose
a more data-driven way of performing the deconvolution. This group of approaches is able to
discover the cell types and their markers as well as approximate profiles of those cell types (perform
“complete deconvolution”). Different types of matrix factorization are suitable for solving this problem.
Even though these deconvolution methods are called reference-free, known reference profiles are used
to interpret and select the cell type-related components. Different possible benefits of reference-free
approaches can be listed as (a) flexibility—discovering the context-dependent cell-type markers,
(b) discovery of new cell types or cell types that are specific to a certain context, (c) determining
deconvoluted profiles of cell types that can be used to remove the immune-related signal or to better
understand the cell type features, and (d) ability to characterize biological processes (such as cell cycle
activity) simultaneously with the cell types.
The reference-free approaches were already applied for deconvolution of cell types in blood using
semi-supervised NMF [71]. They were used to study brain [72], tumoral single cells [73], and cell-cycle
in yeast [74].
In Reference [42] icasso-stabilized fastICA was applied to a set of six large breast cancer patient
cohorts profiled for gene expression. It was demonstrated that the immune-related factors, especially the
signal of T-cell, B-cell, and macrophages were highly reproducible in independent datasets (Figure 5b).
In Reference [75], the DeconICA R package (Available online: https://github.com/UrszulaCzerwinska/
DeconICA) was developed with the objective to apply ICA to the task of cell type deconvolution.
It was shown that ICA is able to efficiently estimate the cell type proportions with better accuracy than
leading supervised algorithms even though it can identify less cell sub-types than most of the published
solutions. It suggests that ICA-based deconvolution is less prone to overfitting and enables discovery
and quantification of strong and stable signals (not necessary the most abundant but rather the most
specific). DeconICA was applied to a big corpus of data containing more than 100 transcriptomic
datasets composed of over 28,000 samples of 40 tumor types generated by different technologies
and processed independently. In addition, the ICA-derived metagenes were used as context-specific
signatures in order to study the characteristics of immune cells in different tumor types. The analysis
revealed a large diversity and plasticity of immune cells dependent and independent on tumor type.
Some conclusions of the study can be helpful in the identification of new drug targets or biomarkers
for immunotherapy of cancer.
Int. J. Mol. Sci. 2019, 20, 4414 17 of 27
Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 17 of 27 
 
 
Figure 5. Examples of utility of ICA for unsupervised deconvolution of cell types. (a) Application of 
ICA to the Sequencing Quality Control consortium (SEQC) dataset [76] containing measurements of 
two references transcriptomic profiles of cell lines and their mixtures at known proportions. The first 
two ICs identify the types and the effect of the platform. (b) Correlation graph among selected 
components from ICA applied to six non-redundant breast cancer transcriptomic datasets. Three 
cliques formed in the graph correspond to major immune cell types. The thickness of the edges reflects 
the absolute correlation value. “Immune” meta-metagene was defined in Reference [33] as the one 
associated with the presence of immune infiltrate in a tumor. This figure was reproduced with 
permission from Reference [42]. 
Cell-type composition can be also computed from DNA methylation data. In the EWAS 
(Epigenome Wide Association Studies), the variation origination from cell types is considered as an 
important confounding factor that should be removed before comparing cases and controls and 
defining Differentially Methylated Positions (DMPs). For example, in Reference [77] ten tools for 
epigenome deconvolution were reviewed. The authors described six reference-free methods, three 
regression-based, and one semi-supervised. Some of these methods use approaches close to ICA, such 
as independent surrogate variable analysis (ISVA) [78], where the goal is to adjust the data for any 
type of confounder (be it cell-type composition or not). Clear superiority of ICA over PCA in 
methylome deconvolution has not been yet demonstrated. Most of the existing tools for unsupervised 
methylome deconvolution assume cell composition as the most contributing to the methylome 
variability. According to Reference [78], this assumption was not proven to hold true in solid tissues, 
normal or pathological. It appears to be interesting to test different approaches to ICA coupled with 
improved reference profiles to check if it cannot open new perspectives in methylome deconvolution. 
3.4. ICA Applications to Single-Cell Omics Data Analysis 
Statistical properties of ICA seem to be very attractive to justify its application to the emerging 
wealth of single-cell omics data profiles. ICA can serve here to improve the data analysis regarding 
dimensionality reduction, removing technical biases, integrating datasets. ICA also looks promising 
and represents an alternative to the standard dimensionality reduction followed by clustering 
methodology for identifying cell types or states, suggesting a more continuous way of considering 
them, with a possibility of existence of intermediate or mixed cell populations. 
Similar to bulk RNA-seq, technical biases and batch effects are limiting factors for single-cell 
RNA-Seq and should be either removed or taken into account. One example of ICA application to 
normalize batch effect was recently reported by Dirkse et al. [79]. The authors observed a strong 
difference between the original patient-derived cell line and its two subpopulations measured in the 
second batch (all cells undergo the same protocol of cell growth and sorting, so biological differences 
Figure 5. Examples of utility of ICA for unsupervised deconvolution of cell types. (a) Application of
ICA to the Sequencing Quality Control consortium (SEQC) dataset [76] containing measurements of two
references transcriptomic profiles of cell lines and their mixtures at known proportions. The first two
ICs identify the types and the effect of the platform. (b) Correlation graph among selected components
from ICA a plied to six non-redundant breast cancer tr scriptomic dataset . Three cliques formed
in the graph cor espond to m jor immune cell types. The thi kness of the edges reflects the ab olute
correla ion value. “Immune” meta-metagene was defined in Refer nc [33] as the one associated
with the presence of immune infiltrate n a t mor. This figure was reproduced with permission from
Reference [42].
Cell-typ composition can be also computed from DNA methylation data. In the EWAS (Epigenome
Wide Association Stu ies), the varia ion origination from cell types is consider d as a mport nt
confounding fact r that should be removed befor c mparing cases and controls and defining
Differentially Methylated Positions (DMPs). For example, in Reference [77] ten tools for epigenome
deconvolution were reviewed. The authors described six reference-free methods, three regression-based,
and one semi-supervised. Some of these methods use approaches close to ICA, such as independent
surrogate variable analysis (ISVA) [78], where the goal is to adjust the data for any type of confounder
(be it cell-type composition or not). Clear superiority of ICA over PCA in methylome deconvolution
has not been yet demonstrated. Most of the existing tools for unsupervised methylome deconvolution
assume cell composition as the most contributing to the methylome variability. According to
Reference [78], this assumption was not proven to hold true in solid tissues, normal or pathological. It
appears to be interesting to test different approaches to ICA coupled with improved reference profiles
to check if it cannot open new perspectives in methylome deconvolution.
3.4. ICA Applications to Single-Cell Omics Data Analysis
Statistical properties of ICA seem to be very attractive to justify its application to the emerging
wealth of single-cell omics data profiles. ICA can serve here to improve the data analysis regarding
dimensionality reduction, removing technical biases, integrating datasets. ICA also looks promising and
represents an alternative to the standard dimensionality reduction followed by clustering methodology
for identifying cell types or states, suggesti g a more c ntinuous way of considering them, with a
possibility of existence of intermedia or mixed c ll populations.
Similar to bulk RNA-seq, technical biases and batch effects are limiting factors for single-cell
RNA-Seq and should be i her removed or tak n into accoun . One example of ICA application to
normalize bat h effect was recently repor e by Dirkse et l. [79]. The authors observ d a strong
difference between the original patient-derived cell line and its two subpopulati ns measured in the
second batch (all cells undergo the same protocol of cell growth and sorting, so biological differences
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were excluded). The difference among batches was comparable to the difference among different
cell lines. The ICA identified and isolated the batch effect in one of the components. By removing
this component and recalculating expression matrix, the authors corrected for this batch effect
(see Figure 6a,b). A similar approach was exploited in Reference [80] in order to pre-process the
single cell data following the trans-differentiation process of murine pre-B cells into macrophages
and their reprogramming into induced pluripotent stem cells. In this study, 15 out of 35 independent
components were considered to be connected with technical artifacts such as sample batch effects and
cell position in the plate and filtered out from the downstream analysis.
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Figure 6. Application of ICA in single cell data analysis of tumors (study of glioblastoma from
Reference [79]). (a) t-distributed stochastic neighbor e bedding (t-SNE) visualization of the data
reveals a strong batch effect. Grey and red/blue dots represent cells from the same cell line, analyzed in
two batches (batch 1—grey dots, batch 2—red and blue cells). The green dots show a cell population
from a different cell line added to the dataset for the reason of comparison. (b) t-SNE visualization of the
data after eliminating signals contained in one IC associated with batch effect. (c) In ICA decomposition
of single cell scRNA-Seq data from cancer studies, usually there exist two components associated
with phases of the cell cycle (G1/S, DNA replication, and G2/M, mitosis). Here the loadings of such
two components are visualized. Black arrows show the regions when the labeled genes are highly
expressed. Yellow arrows show assumed direction of the progression through the cell cycle.
The ICA-based dimensionality reduction is a standard step in the most popular packages for
analyzing single cell RNA-Seq data. In MONOCLE [61,81], ICA is optionally used for the initial step of
dimensionality reduction to 2D, before inferring cellular trajectories. For example, this option was used
in order to derive the cellular trajectory of individual MCF-7 breast cancer cells after stimulating them
with estrogen [82]. It is also part of the popular toolbox Seurat [83] as one of the standard choices for
dimensionality reduction, data visualization, and feature selection. ICA can be exploited, together with
other low-dimensional projections, in various recently developed packages for biologically meaningful
single-cell data visualization [84].
In Reference [85], ICA was applied in rder to efine subtypes of the immune-related cells present
in th TME of mela oma (with original data from Reference [86]) a d relate them to the mechanisms
of innat immune response. ICA was used to defin the continuous spectrum of differenti ti n in
hematopoiet c cells from scRNA-Seq data in R ference [87]; several late t factors were associated
to the underlying bi logical echanisms of differentiation. In R ference [80] t ree independent
components computed for a scRNA-Seq dataset were matched with transcriptional programs specific
to B-cells, macrophages, and monocytes and used to provide an interpreTable 3D data visualization.
Interestingly, in order to establish the biological origin of these components, they were correlated to
the ICA decomposition of the transcriptomic atlas of murine cell types from which 120 independent
components were extracted.
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ICA served as a principal machine learning method for discovering functional subsystems involved
in the response of Ewing sarcoma cells to the induction of the chimeric oncogenic transcription factor
EWSR-FLI1 [62]. In this case, ICA was applied to the temporally resolved single cell RNA-Seq dataset
and revealed the existence of few tens of transcriptional programs activated or inhibited after the
controlled induction of the oncogene. Quite remarkably, one of the independent components was
clearly associated with the functional subsystem composed of the direct targets of EWSR-FLI1, and
it was distinguished from its indirect downstream effects such as cell cycle induction (see Figure 6c).
Other functional subsystems reacting to the variations of the experimental conditions such as hypoxia
or regulation of glucogenesis, were recapitulated in individual ICs. Identification of the functional
subsystems from the cell line experiments were further used in order to characterize the patient-derived
xenografts (PDXs) of Ewing sarcoma, at single cell level.
In principle, ICA is the methodology able to exploit strong non-Gaussianity in the multidimensional
distributions formed by single cells in the space of omics profiles. However, in order to optimally
use this potential, one probably needs to identify the most suitable non-linearity functions, for each
particular type of single cell measurements, and take into account the nature of the multivariate
distribution of points in data space. Recently, a matrix factorization-based method ZINB-WaVE was
adapted to the single cell RNA-Seq measurements, using the model of zero-inflated negative binomial
distribution (ZINB) [88]. In principle, ICA approach can be applied on top of ZINB-WaVE instead of
PCA; however, this approach needs to be tested in practice.
3.5. Multi-Omics ICA Applications in Cancer Research
The majority of published works on applying ICA in cancer research deals with transcriptomic
data. This is connected in part to the relatively high abundance of such data type from collections of
bulk tumors, and in part to the availability of bioinformatics tools helping to interpret the obtained
components (such as Gene Set Enrichment Analysis). Yet another aspect is that transcriptomic data are
better connected so far to the clinical questions such as defining molecular subtypes of tumors.
However, applying ICA should not be limited to only one level of omics profiling, and there is a lot
of potential in applying it to several levels of molecular description. The multi-level datasets become
increasingly available in the cancer biology. The levels of molecular description can be gene copy
number profiles, binary mutation profiles, measured mutational signatures, measured total expression
of genes or spliced mRNA isoforms or non-coding genes such as microRNAs, DNA methylation or
histone mark modification profiling, protein or protein phosphoforms relative abundances or some
other less frequently used omics types. Identification of functional subsystems can be facilitated
through the use of several data types, since the adaptation process is frequently expected to span several
levels. As a good example of such a multi-omics dataset, one can cite recent work on comprehensive
characterization of medulloblastoma [89].
Ideally, several levels of omics profiling should be collected for the same and sufficiently large set
of samples. Independent components can be then computed for each data type separately and then
the identified components can be compared by computing correlations between the corresponding ak
vectors (metasamples). Such an approach was recently applied in Reference [39] to a set of melanoma
bulk samples, profiled at the level of transcriptome and microRNA expression. Similarly, in a recent
study [90], 77 breast and 84 ovarian cancer samples, profiled simultaneously at transcriptome and
proteome level, were analyzed using stabilized ICA, followed by integrating the discovered associations
with clinical data and molecular pathways.
An alternative and somewhat more powerful idea consists in stacking several matrices
corresponding to the different levels of omics profiling into a tensor (multi-dimensional array),
in order to apply the tensorial version of ICA. In this case, ICA will be able to learn and jointly optimize
the signals which can involve variables from several levels of molecular description. This requires
making at least two dimensions of the data common, while the third matrix dimension indicates the
Int. J. Mol. Sci. 2019, 20, 4414 20 of 27
data type. Typically, all molecular measurements are mapped onto the genes through application of
procedures that can be non-trivial (e.g., in the case of Chip-Seq experiments).
The resulting three-dimensional measurement tensor Xijk has dimensions “number of samples
× number of genes × number of data types”. For example, Xi = 4, j = 5, k = 2 element in the tensor
can indicate DNA methylation level of the promoter of the gene 5 in the sample 4. Xi = 4, j = 5, k = 1
could indicate expression of the same gene in the same sample. In the case of tensor factorization,
the resulting components represent matrices rather than vectors having dimensions “number of
genes versus number of data types” (for metagenes) and “number of data types versus number of
samples” (for metasamples). The existence of correlations among different data types within the same
matrix-component indicates coupling among several levels of molecular descriptions captured by
tensorial ICA.
Tensorial ICA was recently applied in Reference [91] to colon cancer dataset from The Cancer
Genome Atlas (TCGA) composed of a matched subset of copy-number variation (CNV), DNAm, and
RNA-seq data. A specific implementation of tensorial ICA called tWFOBI, standing for tensorial
fourth-order blind identification, accompanied by a tensorial version of whitening (W), using tensor
PCA, was used to compute 37 independent components. Most of these components can be associated
with the differences between normal and cancer samples, while only four components capturing
correlations between CNV and gene expression, and one among them was also characterized by
concomitant correlation among all three data types. Of note, the tWFOBI method showed several
orders of magnitude better computational performance compared to the state-of-the-art methods
developed for multi-level omics data integration (such as iCluster).
Applications of ICA to data types other than transcriptomic or to several data types simultaneously
remain limited; however, first applications of this approach in cancer biology are rather promising [91,92].
Multiple issues still remain to be solved for how to define the best practice of ICA application to,
for example, DNA methylation profiles and how to interpret the obtained results. For example,
in Reference [93], a “spatio-temporal” version of ICA was suggested in order to take into account
certain specificity of DNA methylation profiles such as a high level of correlation among probes located
close in the genome. Also, in the case of methylation data, ICA should be carefully benchmarked with
other machine-learning methods exploiting the non-Gaussian nature of signals [94].
3.6. Correlations and Interactions among Functional Subsystems Defined by ICA
Functional subsystems identified through ICA and fixed in the form of metagenes can be studied
for their statistical relationships within a dataset, among datasets of the same kind, or among datasets
that are not closely related in terms of the nature of the biological samples profiled.
In the latter case, one can use ICA for studying disease–disease relationships. An example of such
a relation is the phenomenon of inverse comorbidity between cancer and some other diseases, in terms
of the anti-correlated activation pattern of the common functional subsystems. For example, the ICA
method was exploited in Reference [95] in order to identify inversely associated transcriptional modules
common in breast cancer and Alzheimer’s disease. In a more extensive study [44], 17 transcriptomic
datasets (11 collected for the post-mortal brain samples of patients suffering from Alzheimer’s disease
and six collected for the lung cancer samples) have been analyzed using ICA. The notion of reciprocal
best hit (RBH, see the methodological section of this review) was used in order to match the ICA
components and define their communities. In order to detect the anti-correlation patterns among the
matched components, a specific method was developed to assign an orientation of the components and,
hence, the weight signs in the metagene, based on the analysis of the subset of normal control samples,
in the ak vectors. This analysis confirmed previously identified comorbidity patterns based on the
analysis of individual gene expression profiles (related to the role of immune system and mitochondrial
metabolism) and suggested new molecular mechanisms of comorbidity between lung cancer and
Alzheimer’s disease such as estrogen receptor signaling pathway or the involvement of cadherins.
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Another possibility for exploiting the ICA-based definitions of modules is to study the phenomenon
of functional subsystem integration as a result of adaptation to stress or harmful conditions [63]. It was
shown in many studies that the correlations among the activation patterns of different functional
subsystems can be more informative than the patterns themselves [96]. ICA can deconvolute even
strongly correlated signals (see Figure 2A and the Section 2.2 of this review). Also, it computes
components which are as mutually independent as possible, but the level of dependence can be
different even for subsets of samples within a single dataset. For example, one can expect that in the
normal subset of samples, some of the functional subsystems will be less coupled with each other
than in stressful conditions caused by more aggressive stages of tumorigenesis. This coupling can be
caused by, for example, the shortage of essential metabolic resources making them a common limiting
factor for multiple functional subsystems. If the level of mutual information between two signals
increases above the ability of ICA to discriminate components, then these signals will be captured by
one independent component. This phenomenon of independent component splitting and merging might
depend on the order of ICA decomposition (and it was empirically studied in Reference [34]), on the
specific biases in the composition of samples, or on the number of samples.
The theoretical principles of functional subsystems integration have been developed [63,64].
However, it remains an interesting problem to verify and apply them to the concrete modules identifiable
from the (multi-)-omics profiles. Independent Component Analysis represents an interesting option
for achieving this objective.
4. Discussion
In recent decades, independent component analysis has become a standard tool for the analysis
of tables of omics measurements in cancer biology. In certain applications, it was shown to have
advantages, especially in terms of reproducibility or generalizability and biological interpretability,
compared to other popular matrix factorization methods. Despite ICA being shown to be a useful
tool, it seems to be under-appreciated partly due to the fact of historical reasons and partly due to the
presence of existing confusions in the underlying assumptions and/or interpretation of the resulting
matrix decompositions. For example, it is frequently commented that biological processes are not
perfectly independent and that they are expected to be correlated in some conditions. Even though this
is true, ICA can distinguish signals coupled to some extent by making the corresponding components
as independent as possible.
In this review, we made a comprehensive effort to mention most of the recent studies in cancer
research where ICA served as the essential data analysis tool. We classified them into several
common topics: data preprocessing, data dimension reduction and visualization, identification of
functional subsystems and their correlations or interactions, deconvolution of cell types, data integration
and meta-analysis.
We also reviewed the methodological works aimed at defining the best practices of applying
ICA to concrete types of omics data. Compared to the early times of applying ICA to omics datasets,
today there exists a variety of implementations and improved methodologies allowing us to use
the valuable idea behind ICA (exploiting the concept of statistical independence and use of higher
moments of multivariate data distributions) in the best possible way. Certain progress has been made
in clarifying such important questions such as determining the optimal number of components to
retain or establishing the biological significance of the extracted components.
Most of the existing applications of ICA have been done so far for transcriptomic data even
if the interpretation of the components used other types of molecular data (such as mutations,
copy number alterations). Since recently, ICA started to be applied to other types of omics profiles,
including methylation profiles and proteomics datasets. It seems interesting to determine, using ICA,
independent sources of variance in newly emerging omics data types, such as systematic Chip-Seq
datasets mapping the state of histone modifications or mutational signature profiles. More experience,
standardization and assessment are required to use ICA in the most optimal way for the analysis of
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single-cell and multi-omics datasets. Moreover, in this review we did not even mention other fields of
ICA application in cancer biology, including the analysis of imaging data (e.g., [97]), clinical records,
and other non-omics data types, for which the ICA data model might be of interest.
Matrix factorization represents an alternative approach to the standard clustering methods,
being more flexible in terms of taking into account gene plurifunctionality and ability for unsupervised
deconvolution of factors whose activity can be correlated. It is worth noticing that some ICA algorithms
(such as fastICA) are computationally performant when properly implemented and potentially able to
deal with large amounts of molecular measurements. In this sense, ICA remains competitive vis-a-vis
many other approaches (e.g., based on likelihood maximization or representation of the data in the
form of multilayered networks).
We believe there are interesting directions to further explore and more deeply use the concepts
behind ICA in the context of cancer biology data analyses. It would be interesting to reconsider the
roots of independent component analysis into artificial neural network methodology, suggesting novel
scalable autoencoding-based techniques in order to solve the problem of blind source separation
adapted to the nature of the biological data. Assessing the value of supervised learning of the
features extracted by ICA from omics and other data types and comparing them to “hand-crafted”
or convolutional neural network-based features can lead to designing performant hybrid learning
approaches, as in Reference [98]. It appears promising to take advantage of the wealth of recently
emerged formalized knowledge on biological mechanisms of cancer and develop methods to inject
this knowledge into the component learning process. The biological factors or functional subsystems
in cells or cellular ecosystems are organized in complex hierarchies, and we need new approaches to
explicitly take this into account, in order to improve the subsystems identifiably.
To conclude, as a team of authors all having extensive experience in applying independent
component analysis as a tool in computational cancer biology, we advocate for its wider use in making
sense of the growing amount of omics data in this and other fields.
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